Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia

McCubrey, James A.2022-01-312022-01-312016-08-231949-2553http://hdl.handle.net/10342/9592en-UST lymphocytesPI3K/Akt/mTOR signalingT-acute lymphoblastic leukemiaHealthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic LeukemiaArticle10.18632/oncotarget.10984